Fusarium falciforme vertebral abscess and osteomyelitis: Case report and molecular classification

Journal of Clinical Microbiology

Volumn 49, Issue 6, 2011, Pages 2350-2353

  Edupuganti, Srilatha ^a   Rouphael, Nadine ^a   Mehta, Aneesh ^a   Eaton, Molly ^a   Heller, John G ^a   Bressler, Adam ^b   Brandt, Mary ^c   O'Donnell, Kerry ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Atlanta Infectious Diseases Group Professional Corporation   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CENTER FOR AGRICULTURAL UTILIZATION RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; POSACONAZOLE; VORICONAZOLE;

ABSCESS; ADULT; ARACHNOIDITIS; ARTICLE; BACKACHE; CASE REPORT; CLINICAL FEATURE; DEBRIDEMENT; DISEASE COURSE; DISEASE DURATION; DRUG DOSE INCREASE; FEMALE; FUNGAL DETECTION; FUSARIOSIS; FUSARIUM FALCIFORME VERTEBRAL ABSCESS; FUSARIUM SOLANI; HEART INFARCTION; HUMAN; LAMINECTOMY; LIMB WEAKNESS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PARAPLEGIA; PHYSIOTHERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SPINAL CORD STIMULATION; SPINAL CORD TUMOR;

DNA, FUNGAL; EPIDURAL ABSCESS; FEMALE; FUSARIUM; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; MYCOLOGICAL TYPING TECHNIQUES; MYCOSES; OSTEOMYELITIS; SEQUENCE ANALYSIS, DNA; SPONDYLITIS;

FUSARIUM; FUSARIUM FALCIFORME;

EID: 79957527597     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02547-10     Document Type: Article

References (21)

1. Alastruey-Izquierdo, A., M. Cuenca-Estrella, A. Monzón, E. Mellado, and J. L. Rodríguez-Tudela. 2008. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J. Antimicrob. Chemother. 61:805-809.
2. Balajee, S. A., et al. 2009. Sequence-based identification of Aspergillus, Fusarium, and Mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J. Clin. Microbiol. 47:877-884.
3. Boutati, E. I., and E. J. Anaissie. 1997. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 90:999-1008.
4. Chang, D. C., et al. 2006. A multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA 296:953-963. (Pubitemid 44285372)
5. Dignani, M. C., and E. Anaissie. 2004. Human fusariosis. Clin. Microbiol. Infect. 10:67-75.
6. Geiser, D. M., et al. 2004. FUSARIUM-ID v. 1.0: a DNA sequence database for identifying Fusarium. Eur. J. Plant Pathol. 110:473-479.
7. Hue, F.-X., M. Huerre, M. A. Rouffault, and C. de Bievre. 1999. Specific detection of Fusarium species in blood and tissues by a PCR technique. J. Clin. Microbiol. 37:2434-2438.
8. Leslie, J. F., and B. A. Summerell. 2006. The Fusarium laboratory manual. Blackwell Publishing, Ames, IA.
9. Moschovi, M., et al. 2004. Subacute vertebral osteomyelitis in a child with diabetes mellitus associated with Fusarium. Pediatr. Int. 46:740-742.
10. Nelson, P. E., M. C. Dignani, and E. J. Anaissie. 1994. Taxonomy, biology, and clinical aspects of Fusarium species. Clin. Microbiol. Rev. 7:479-504.
11. Nucci, M., and E. Anaissie. 2002. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin. Infect. Dis. 35:909-920.
12. Nucci, M., and E. Anaissie. 2007. Fusarium infections in immunocompromised patients. Clin. Microbiol. Rev. 20:695-704.
13. O'Donnell, K., et al. 2008. Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J. Clin. Microbiol. 46:2477-2490.
14. O'Donnell, K., et al. 2010. Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J. Clin. Microbiol. 48:3708-3718.
15. Palmore, T. N., Y. R. Shea, R. W. Childs, R. M. Sherry, and T. J. Walsh. 2010. Fusarium proliferatum soft tissue infection at the site of plant trauma: recovery, isolation, and direct molecular identification. J. Clin. Microbiol. 48:338-341.
16. Reuben, A., et al. 1989. Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method. Antimicrob. Agents Chemother. 33:1647-1649.
17. Sierra-Hoffman, M., S. Paltiyevich-Gibson, J. L. Carpenter, and D. L. Hurley. 2005. Fusarium osteomyelitis: case report and review of the literature. Scand. J. Infect. Dis. 37:237-240.
18. Sutton, D. A., and M. E. Brandt. Fusarium and other opportunistic hyaline fungi. In J. Versalovic, K. C. Carroll, G. Funke, J. H. Jorgensen, M. L. Landry, and D. W. Warnock (ed.), Manual of clinical microbiology. ASM Press, Washington, DC, in press.
19. Swofford, D. L. 2002. PAUP*. Phylogenetic analysis using parsimony (*and other methods), version 4. Sinauer Associates, Sunderland, MA.
20. Zhang, N., et al. 2006. Members of the Fusarium solani species complex that cause infections in both humans and plants are common in the environment. J. Clin. Microbiol. 44:2186-2190.
21. Zwickl, D. J. 2006. Genetic algorithm approaches for the phylogenetic analysis of large biological sequence data sets under the maximum likelihood criterion. Ph.D. dissertation, the University of Texas at Austin, Austin, TX.